Timing of percutaneous endoscopic gastrostomy tube placement in post-stroke patients does not impact mortality, complications, or outcomes

doi:10.4292/wjgpt.v13.i5.77

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 5

This Article

(213)

(201)

(0)

(5337)

(13)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Study

World J Gastrointest Pharmacol Ther. Sep 5, 2022; 13(5): 77-87
Published online Sep 5, 2022. doi: 10.4292/wjgpt.v13.i5.77

Table 2 Patient comorbidities

Types of comorbidities	All (N = 154)		PEG ≤ 7 d (N = 62, 40.26%)		PEG > 7 d (N = 92, 59.74%)		P value
Types of comorbidities	N	%	N	%	N	%	P value
Acute respiratory distress syndrome	1	0.65	0	0.00	1	1.09	1.0000¹
Acute kidney injury	2	1.30	0	0.00	2	2.17	0.5158
Alcohol abuse	5	3.25	2	3.23	3	3.26	1.0000¹
Amyotrophic lateral sclerosis	1	0.65	0	0.00	1	1.09	1.0000¹
Anemia	4	2.60	2	3.23	2	2.17	1.0000¹
Aortic dissection	1	0.65	0	0.00	1	1.09	1.0000¹
Aortic stenosis	1	0.65	0	0.00	1	1.09	1.0000¹
Arrhythmias	7	4.55	4	6.45	3	3.26	0.4403¹
Atrial fibrillation	32	20.78	17	27.42	15	16.30	0.0955
Breast cancer	3	1.95	2	3.23	1	1.09	0.5652¹
Coronary artery disease	29	18.83	9	14.52	20	21.74	0.2609
Cirrhosis	1	0.65	1	1.61	0	0.00	0.4026¹
Chronic kidney disease	14	9.09	2	3.23	12	13.04	0.0377
Colon cancer	2	1.30	2	3.23	0	0.00	0.1605¹
Chronic obstructive pulmonary disease	9	5.84	1	1.61	8	8.70	0.0853¹
Dementia	15	9.74	5	8.06	10	10.87	0.5648
Diabetes mellitus	52	33.77	19	30.65	33	35.87	0.5014
Deep vein thrombosis	1	0.65	1	1.61	0	0.00	0.4026¹
Heart failure	24	15.58	11	17.74	13	14.13	0.5445
Hyperlipidemia	45	29.22	20	32.26	25	27.17	0.4963
Hypertension	121	78.57	45	72.58	76	82.61	0.1369
Lung cancer	1	0.65	0	0.00	1	1.09	1.0000¹
Nonalcoholic steatohepatitis	1	0.65	0	0.00	1	1.09	1.0000¹
Obstructive sleep apnea	3	1.95	1	1.61	2	2.17	1.0000¹
Peripheral artery disease	6	3.90	5	8.06	1	1.09	0.0391¹
Parkinson's disease	2	1.30	0	0.00	2	2.17	0.5158¹
Patent Foramen Ovale	1	0.65	1	1.61	0	0.00	0.4026¹
Prostate cancer	2	1.30	0	0.00	2	2.17	0.5158¹
Pulmonary hypertension	1	0.65	1	1.61	0	0.00	0.4026¹
Seizure disorder	4	2.60	2	3.23	2	2.17	1.0000¹
Stroke	38	24.68	14	22.58	24	26.09	0.6206¹
Substance abuse	1	0.65	0	0.00	1	1.09	1.0000¹
Thrombocytopenia	2	1.30	1	1.61	1	1.09	1.0000¹
Thyroid cancer	1	0.65	1	1.61	0	0.00	0.4026¹

¹Obtained by Fisher's Exact Test, PEG: Percutaneous endoscopic gastrostomy, Significant P values are in bold.

Full Size Table

Citation: Reddy KM, Lee P, Gor PJ, Cheesman A, Al-Hammadi N, Westrich DJ, Taylor J. Timing of percutaneous endoscopic gastrostomy tube placement in post-stroke patients does not impact mortality, complications, or outcomes. World J Gastrointest Pharmacol Ther 2022; 13(5): 77-87
URL: https://www.wjgnet.com/2150-5349/full/v13/i5/77.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v13.i5.77

Reddy KM, Lee P, Gor PJ, Cheesman A, Al-Hammadi N, Westrich DJ, Taylor J. Timing of percutaneous endoscopic gastrostomy tube placement in post-stroke patients does not impact mortality, complications, or outcomes. World J Gastrointest Pharmacol Ther 2022; 13(5): 77-87 [PMID: 36157266 DOI: 10.4292/wjgpt.v13.i5.77]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.